@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix rgd: . @prefix geneProductOf: . @prefix proteinModification: . @prefix psimod: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: rgd:1311069; a Protein: . sub:_2 belv:variantOf rgd:2939; a proteinModification:, psimod:00696 . sub:_3 occursIn: species:10116; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(RGD:Mpl) -> p(RGD:Jak2,pmod(P))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "1.4" . sub:_4 prov:value "Treatment of hippocampal neurons with thrombopoietin (TPO) for 15 hours at concentrations as low as 10 pM, increased the spontaneous cell death rate by >60%; treatment with AG-490 (20 microM), an inhibitor of JAK2-transphosphorylation, and PD-98059 (50 microM), an inhibitor of ERK1/2, completely eliminated TPO-induced neuronal death, as did the caspase-3 inhibitor Ac-VAD-CHO (50 microM), suggesting that receptor mediated activation of JAK2 and ERK1/2 are involved in caspase-3 activation and cell death in TPO treated hippocampal neurons."; prov:wasQuotedFrom pubmed:15642952 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15642952; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:30.797+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }